KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Gross Profit (2016 - 2025)

Bristol Myers Squibb has reported Gross Profit over the past 18 years, most recently at $8.1 billion for Q1 2026.

  • Quarterly Gross Profit fell 1.22% to $8.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $34.2 billion through Mar 2026, up 1.76% year-over-year, with the annual reading at $34.3 billion for FY2025, 0.22% changed from the prior year.
  • Gross Profit was $8.1 billion for Q1 2026 at Bristol Myers Squibb, down from $8.4 billion in the prior quarter.
  • Over five years, Gross Profit peaked at $9.2 billion in Q1 2022 and troughed at $7.5 billion in Q4 2024.
  • The 5-year median for Gross Profit is $8.8 billion (2025), against an average of $8.6 billion.
  • Year-over-year, Gross Profit fell 13.77% in 2024 and then rose 11.62% in 2025.
  • A 5-year view of Gross Profit shows it stood at $8.8 billion in 2022, then decreased by 0.92% to $8.7 billion in 2023, then fell by 13.77% to $7.5 billion in 2024, then rose by 11.62% to $8.4 billion in 2025, then dropped by 4.01% to $8.1 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Gross Profit are $8.1 billion (Q1 2026), $8.4 billion (Q4 2025), and $8.8 billion (Q3 2025).